The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Recurrent antibiotic exposure may promote cancer formation – Another step in understanding the role of the human microbiota?
Open accessAbstract
Background Bacterial dysbiosis was previously described in human malignancies. In a recent animal model, tumor susceptibility was transmitted using fecal transplantation. Our aim was to further evaluate possible association between antibiotic exposure and cancer risk. Methods We conducted nested case-control studies for 15 common malignancies using a large population-based electronic medical records database. Cases were defined as those with any medical code for the specific malignancy. Individuals with familial cancer syndromes were excluded. For every case, four eligible controls matched on age, sex, practice site, and duration of follow-up before index-date were selected using incidence-density sampling. Exposure of interest was antibiotic therapy >1 year before index-date. Adjusted odds-ratios (AORs) and 95%CIs were estimated for each antibiotic type using conditional logistic regression. Results 125,441 cases and 490,510 matched controls were analyzed. For gastro-intestinal malignancies, the use of penicillin was associated with an elevated risk of esophageal, gastric, and pancreatic cancers. The association increased with the number of antibiotic courses and reached 1.4 for gastric cancers associated with >5 courses of penicillin (95%CI 1.2–1.8). Lung cancer risk increased with the use of penicillin, cephalosporines, or macrolides (AOR for >5 courses of penicillin: 1.4 95%CI 1.3–1.6). The risk of prostate cancer increased modestly with the use of penicillin, quinolones, sulphonamides and tetracyclines. The risk for breast cancer was modestly associated with exposure to sulphonamides. There was no association between use of anti-virals and anti-fungals and cancer risk. Conclusion Recurrent exposure to certain antibiotics may be associated with cancer risk in specific organ sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Role of the gut microbiota in immunity and inflammatory disease
Kamada, N., Seo, S.-U., Chen, G. Y., & Núñez, G. (2013) · Nature reviews. Immunology · doi:10.1038/nri3430 · Cited by 2,256
The keystone-pathogen hypothesis
Hajishengallis, G., Darveau, R. P., & Curtis, M. A. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2873 · Cited by 1,790
Jakobsson, H. E., Jernberg, C., Andersson, A. F., Sjölund-Karlsson, M., Jansson, J. K., & Engstrand, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009836 · Cited by 1,160
Microbial Dysbiosis in Colorectal Cancer (CRC) Patients
Sobhani, I., Tap, J., Roudot-Thoraval, F., Roperch, J. P., Letulle, S., Langella, P., Corthier, G., Van Nhieu, J. T., & Furet, J. P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016393 · Cited by 842
Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer
Farrell, J. J., Zhang, L., Zhou, H., Chia, D., Elashoff, D., Akin, D., Paster, B. J., Joshipura, K., & Wong, D. T. W. (2012) · Gut · doi:10.1136/gutjnl-2011-300784 · Cited by 662
Stool microbiome and metabolome differences between colorectal cancer patients and healthy adults
Weir, T. L., Manter, D. K., Sheflin, A. M., Barnett, B. A., Heuberger, A. L., & Ryan, E. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070803 · Cited by 642 · cited 1×
“Numerous mechanisms have been proposed to explain the association between bacterial dysbiosis and cancer risk, including induction of chronic inflammation; changes in the normal tissue metabolism; direct genotoxic effects; and weakening of the immune response [5,9–13].”
BackgroundBlak, B., Thompson, M., Dattani, H., & Bourke, A. (2011) · Journal of Innovation in Health Informatics · doi:10.14236/jhi.v19i4.820 · Cited by 630
Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., & Strom, B. L. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1335 · Cited by 602
Microbial Dysbiosis Is Associated with Human Breast Cancer
Xuan, C., Shamonki, J. M., Chung, A., DiNome, M. L., Chung, M., Sieling, P. A., & Lee, D. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0083744 · Cited by 543
High Prevalence of Mucosa-Associated E. coli Producing Cyclomodulin and Genotoxin in Colon Cancer
Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., & Bonnet, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056964 · Cited by 535
High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity
Schulz, M. D., Atay, Ç., Heringer, J., Romrig, F. K., Schwitalla, S., Aydin, B., Ziegler, P. K., Varga, J., Reindl, W., Pommerenke, C., et al. (2014) · Nature · doi:10.1038/nature13398 · Cited by 453
Biased Selection of Controls for Case-Control Analyses of Cohort Studies
Lubin, J. H., & Gail, M. H. (1984) · Biometrics · doi:10.2307/2530744 · Cited by 414
García Rodríguez, L. A., & Huerta-Alvarez, C. (2001) · Epidemiology · doi:10.1097/00001648-200101000-00015 · Cited by 359
Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Antibiotic Use in Relation to the Risk of Breast Cancer
Velicer, C. M. (2004) · JAMA · doi:10.1001/jama.291.7.827 · Cited by 331
Gastrointestinal Malignancy and the Microbiome
Abreu, M. T., & Peek, R. M. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.001 · Cited by 322
Maguire, A., Blak, B. T., & Thompson, M. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1688 · Cited by 301
URINARY TRACT INFECTION AND RISK OF BLADDER CANCER
KANTOR, A. F., HARTGE, P., HOOVER, R. N., NARAYANA, A. S., SULLIVAN, J. W., & FRAUMENI, J. F. (1984) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113768 · Cited by 277
The problem of “protopathic bias” in case-control studies
Horwitz, R. I., & Feinstein, A. R. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90363-0 · Cited by 235
Cheng, M., Qian, L., Shen, G., Bian, G., Xu, T., Xu, W., Shen, G., & Hu, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2462 · Cited by 182
Gut Microbiome and Colorectal Adenomas
Dulal, S., & Keku, T. O. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000050 · Cited by 124
Antibiotic use predicts an increased risk of cancer
Kilkkinen, A., Rissanen, H. A., Klaukka, T., Pukkala, ., Heliövaara, M., Huovinen, P., Männistö, S., Aromaa, A., & Knekt, P. (2008) · International Journal of Cancer · doi:10.1002/ijc.23622 · Cited by 122
Impact of antibiotic exposure on the risk of colorectal cancer
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 96
Self-citationAcne and risk of prostate cancer
Sutcliffe, S., Giovannucci, E. L., Isaacs, W. B., Willett, W. C., & Platz, E. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23032 · Cited by 81
Cancer incidence in The Health Improvement Network
Haynes, K., Forde, K. A., Schinnar, R., Wong, P., Strom, B. L., & Lewis, J. D. (2009) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1774 · Cited by 66
Self-citationAntibiotic Use and the Risk of Lung Cancer
Zhang, H., Rodríguez, L. A. G., & Hernández–Dı́az, S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2817 · Cited by 53
Microbiota and innate immunity in intestinal inflammation and neoplasia
Cario, E. (2012) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835a670e · Cited by 47
Trends in Antibiotic Prescribing in Adults in Dutch General Practice
Haeseker, M. B., Dukers–Muijrers, N. H. T. M., Hoebe, C. J. P. A., Bruggeman, C. A., Cals, J., & Verbon, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051860 · Cited by 35
Association between antibiotic use and risk of prostate cancer
Tamim, H., Hajeer, A. H., Boivin, J., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.25139 · Cited by 21
Cited by
The microbiome, cancer, and cancer therapy
Helmink, B. A., Khan, M. A. W., Hermann, A., Gopalakrishnan, V., & Wargo, J. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0377-7 · Cited by 1,200
Gut microbiota and Covid-19- possible link and implications
Dhar, D., & Mohanty, A. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198018 · Cited by 608
The Intestinal Microbiome and Estrogen Receptor–Positive Female Breast Cancer
(2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw029 · Cited by 523
Microbiome and Anticancer Immunosurveillance
Zitvogel, L., Ayyoub, M., Routy, B., & Kroemer, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.001 · Cited by 478
Interaction between the microbiome and TP53 in human lung cancer
Greathouse, K. L., White, J. R., Vargas, A. J., Bliskovsky, V. V., Beck, J. A., von Muhlinen, N., Polley, E. C., Bowman, E. D., Khan, M. A., Robles, A. I., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1501-6 · Cited by 446
Metadata
- Authors
- Boursi, B., Mamtani, R., Haynes, K., & Yang, Y.-X.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 51
- Issue
- 17
- Pages
- 2655-2664
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W1266271947
- Cited by
- 263
- References
- 30
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.